Last Price
0.006
Today's Change
-0.001 (14.28%)
Day's Change
0.006 - 0.006
Trading Volume
7,150,000
Overview
Market Cap
27 Million
Shares Outstanding
4 Billion
Avg Volume
7,370,303
Avg Price (50 Days)
0.01
Avg Price (200 Days)
0.01
PE Ratio
-0.60
EPS
-0.01
Earnings Announcement
26-Feb-2025
Previous Close
0.01
Open
0.01
Day's Range
0.006 - 0.006
Year Range
0.004 - 0.015
Trading Volume
7,150,000
Price Change Highlight
1 Day Change
-14.29%
5 Day Change
-14.29%
1 Month Change
-14.29%
3 Month Change
-50.00%
6 Month Change
20.00%
Ytd Change
-29.42%
1 Year Change
-29.42%
3 Year Change
-78.61%
5 Year Change
-95.25%
10 Year Change
-90.16%
Max Change
-96.66%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Medical Devices
Description:
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
2
CEO Morning Brief
Australia's Government Spends Its Way to Bigger Budget Deficits
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
